California 2023-2024 Regular Session

California Assembly Bill AR120 Latest Draft

Bill / Introduced Version Filed 08/13/2024

                            CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION House Resolution No. 120Introduced by Assembly Member CalderonAugust 13, 2024 Relative to Blood Cancer Awareness Month. LEGISLATIVE COUNSEL'S DIGESTHR 120, as introduced, Calderon. Digest KeyBill TextWHEREAS, Each September, national Blood Cancer Awareness Month emphasizes the symptoms, causes, and ongoing innovations in the treatment of cancers of the blood and lymphatic systems; andWHEREAS, This month is dedicated to raising awareness about the various forms of blood cancers, including leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes, with the aim of educating the public on their causes, symptoms, treatments, and research advancements; andWHEREAS, Blood cancers primarily affect white blood cells and may, in certain cases, also target red blood cells or platelets. In the absence of definitive screening methods, it is crucial to recognize symptoms and risk factors to seek timely medical intervention; andWHEREAS, Common symptoms of blood cancers include swelling of the lymph nodes, persistent fatigue, night sweats, fever, shortness of breath, and unexpected weight loss; andWHEREAS, Risk factors encompass family history, genetic disorders, lifestyle choices, such as smoking, and exposure to radiation or chemotherapy; andWHEREAS, The United States witnesses approximately 14,000 new cases of blood cancers each month. Although the survival rates for diseases such as leukemia have significantly improved since the 1960s, these rates vary depending on the specific type of cancer and are influenced by ongoing scientific advancements; andWHEREAS, Every nine minutes, an individual in the United States succumbs to blood cancer, representing nearly 10 percent of all cancer-related deaths in the nation; andWHEREAS, In 2024, it is estimated that an alarming number of Californians will be diagnosed with leukemia; andWHEREAS, Leukemia accounts for approximately one-third of all childhood cancer cases, making it the most prevalent cancer among children; andWHEREAS, Leaders in medicine and bioscience have tirelessly sought solutions, developing next-generation treatments to dramatically improve the lives of patients affected by blood cancer; andWHEREAS, By fostering collaborations and partnerships across the scientific, medical, patient, and caregiver support sectors, these leaders underscore a unified commitment to finding cures and transforming lives; and WHEREAS, Efforts within our communities to promote dialogue and education about blood cancers significantly contribute to the overall well-being of all Californians; andWHEREAS, It is essential to intensify awareness and action on this critical health issue at the local, state, and national levels; now, therefore, be itResolved by the Assembly of the State of California, That the Assembly hereby designates September 2024 as Blood Cancer Awareness Month in the State of California; and be it furtherResolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.

 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION House Resolution No. 120Introduced by Assembly Member CalderonAugust 13, 2024 Relative to Blood Cancer Awareness Month. LEGISLATIVE COUNSEL'S DIGESTHR 120, as introduced, Calderon. Digest Key





 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION

 House Resolution 

No. 120

Introduced by Assembly Member CalderonAugust 13, 2024

Introduced by Assembly Member Calderon
August 13, 2024

 Relative to Blood Cancer Awareness Month. 

LEGISLATIVE COUNSEL'S DIGEST

## LEGISLATIVE COUNSEL'S DIGEST

HR 120, as introduced, Calderon. 



## Digest Key

## Bill Text

WHEREAS, Each September, national Blood Cancer Awareness Month emphasizes the symptoms, causes, and ongoing innovations in the treatment of cancers of the blood and lymphatic systems; and

WHEREAS, This month is dedicated to raising awareness about the various forms of blood cancers, including leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes, with the aim of educating the public on their causes, symptoms, treatments, and research advancements; and

WHEREAS, Blood cancers primarily affect white blood cells and may, in certain cases, also target red blood cells or platelets. In the absence of definitive screening methods, it is crucial to recognize symptoms and risk factors to seek timely medical intervention; and

WHEREAS, Common symptoms of blood cancers include swelling of the lymph nodes, persistent fatigue, night sweats, fever, shortness of breath, and unexpected weight loss; and

WHEREAS, Risk factors encompass family history, genetic disorders, lifestyle choices, such as smoking, and exposure to radiation or chemotherapy; and

WHEREAS, The United States witnesses approximately 14,000 new cases of blood cancers each month. Although the survival rates for diseases such as leukemia have significantly improved since the 1960s, these rates vary depending on the specific type of cancer and are influenced by ongoing scientific advancements; and

WHEREAS, Every nine minutes, an individual in the United States succumbs to blood cancer, representing nearly 10 percent of all cancer-related deaths in the nation; and

WHEREAS, In 2024, it is estimated that an alarming number of Californians will be diagnosed with leukemia; and

WHEREAS, Leukemia accounts for approximately one-third of all childhood cancer cases, making it the most prevalent cancer among children; and

WHEREAS, Leaders in medicine and bioscience have tirelessly sought solutions, developing next-generation treatments to dramatically improve the lives of patients affected by blood cancer; and

WHEREAS, By fostering collaborations and partnerships across the scientific, medical, patient, and caregiver support sectors, these leaders underscore a unified commitment to finding cures and transforming lives; and 

WHEREAS, Efforts within our communities to promote dialogue and education about blood cancers significantly contribute to the overall well-being of all Californians; and

WHEREAS, It is essential to intensify awareness and action on this critical health issue at the local, state, and national levels; now, therefore, be it

Resolved by the Assembly of the State of California, That the Assembly hereby designates September 2024 as Blood Cancer Awareness Month in the State of California; and be it further

Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.